Published by Benjamin Chiou on 18th September 2025
(Sharecast News) - Shares in American clinical-stage biopharmaceutical company 89bio rocketed in pre-market trade on Thursday after Swiss pharma giant Roche struck a deal to buy the outfit for up to $3.5bn.
URL: http://www.digitallook.com/dl/news/story/35362858/...